Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Exclusion Criteria

• •Subjects meeting any of the following criteria:
• •The Investigator believes that it would not be in the best interest of the subject to be included in the LTE e.g., for clinical or social reasons.
• •Subjects who were not compliant with study medication in AV-101-002 as assessed by the Investigator.